VRCA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Verrica Pharmaceuticals Inc (VRCA).


$31.92M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

VRCA Market Cap. (MRY)


VRCA Shares Outstanding (MRY)


VRCA Assets (MRY)


Total Assets

$54.13M

Total Liabilities

$63.99M

Total Investments

$0

VRCA Income (MRY)


Revenue

$7.57M

Net Income

-$76.58M

Operating Expense

$70.75M

VRCA Cash Flow (MRY)


CF Operations

-$60.93M

CF Investing

-$19.00K

CF Financing

$37.73M

VRCA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

VRCA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$54,134,000 (-33.66%)

$81,597,000 (82.46%)

$44,721,000 (-44.19%)

$80,125,000 (8.05%)

Assets Current

$51,179,000 (-33.99%)

$77,530,000 (98.21%)

$39,115,000 (-47.38%)

$74,328,000 (9.87%)

Assets Non-Current

$2,955,000 (-27.34%)

$4,067,000 (-27.45%)

$5,606,000 (-3.29%)

$5,797,000 (-10.87%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$9,860,000 (-149.89%)

$19,763,000 (-50.63%)

$40,033,000 (22.78%)

$32,605,000 (-1.16%)

Property Plant & Equipment Net

$2,579,000 (-28.66%)

$3,615,000 (-32.18%)

$5,330,000 (-3.13%)

$5,502,000 (11.42%)

Cash & Equivalents

$46,329,000 (-33.38%)

$69,547,000 (102.92%)

$34,273,000 (117.58%)

$15,752,000 (47.41%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

-$29,000 (-3000.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$54,602,000 (-0.33%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$54,602,000 (-0.33%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,463,000 (141.00%)

$1,022,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$77,000 (-98.26%)

$4,416,000 (806.78%)

$487,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,896,000 (-23.05%)

$2,464,000 (386.00%)

$507,000 (-40.00%)

$845,000 (142.82%)

Accumulated Retained Earnings (Deficit)

-$307,027,000 (-33.23%)

-$230,448,000 (-40.99%)

-$163,453,000 (-17.62%)

-$138,966,000 (-33.77%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$45,939,000 (0.94%)

$45,510,000 (2882.31%)

$1,526,000 (-96.48%)

$43,409,000 (16.67%)

Debt Current

$13,605,000 (1843.57%)

$700,000 (135.69%)

$297,000 (-99.29%)

$41,944,000 (18.11%)

Debt Non-Current

$32,334,000 (-27.84%)

$44,810,000 (3546.05%)

$1,229,000 (-16.11%)

$1,465,000 (-13.47%)

Total Liabilities

$63,994,000 (3.49%)

$61,834,000 (1218.98%)

$4,688,000 (-90.13%)

$47,520,000 (15.43%)

Liabilities Current

$29,012,000 (70.42%)

$17,024,000 (392.17%)

$3,459,000 (-92.49%)

$46,055,000 (16.67%)

Liabilities Non-Current

$34,982,000 (-21.93%)

$44,810,000 (3546.05%)

$1,229,000 (-16.11%)

$1,465,000 (-13.47%)

VRCA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$7,566,000 (47.66%)

$5,124,000 (-43.27%)

$9,032,000 (-24.73%)

$12,000,000 (0%)

Cost of Revenue

$2,740,000 (267.29%)

$746,000 (2.90%)

$725,000 (0%)

$0 (0%)

Selling General & Administrative Expense

$58,822,000 (24.35%)

$47,305,000 (171.79%)

$17,405,000 (-35.49%)

$26,979,000 (10.08%)

Research & Development Expense

$11,840,000 (-41.66%)

$20,295,000 (66.38%)

$12,198,000 (-23.42%)

$15,929,000 (1.63%)

Operating Expenses

$70,745,000 (0.87%)

$70,137,000 (136.93%)

$29,603,000 (-31.01%)

$42,908,000 (6.79%)

Interest Expense

$9,412,000 (137.56%)

$3,962,000 (82.41%)

$2,172,000 (-49.43%)

$4,295,000 (41.56%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$76,579,000 (-14.31%)

-$66,995,000 (-173.59%)

-$24,487,000 (30.20%)

-$35,080,000 (17.83%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$76,579,000 (-14.31%)

-$66,995,000 (-173.59%)

-$24,487,000 (30.20%)

-$35,080,000 (17.83%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$76,579,000 (-14.31%)

-$66,995,000 (-173.59%)

-$24,487,000 (30.20%)

-$35,080,000 (17.83%)

Weighted Average Shares

$51,808,228 (14.26%)

$45,342,451 (32.72%)

$34,163,437 (26.32%)

$27,044,462 (8.20%)

Weighted Average Shares Diluted

$51,808,228 (14.26%)

$45,342,451 (32.72%)

$34,163,437 (26.32%)

$27,044,462 (8.20%)

Earning Before Interest & Taxes (EBIT)

-$67,167,000 (-6.56%)

-$63,033,000 (-182.47%)

-$22,315,000 (27.51%)

-$30,785,000 (22.38%)

Gross Profit

$4,826,000 (10.23%)

$4,378,000 (-47.30%)

$8,307,000 (-30.78%)

$12,000,000 (0%)

Operating Income

-$65,919,000 (-0.24%)

-$65,759,000 (-208.79%)

-$21,296,000 (31.10%)

-$30,908,000 (23.08%)

VRCA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$19,000 (94.75%)

-$362,000 (-100.67%)

$54,041,000 (5514.93%)

-$998,000 (72.12%)

Net Cash Flow from Financing

$37,728,000 (-49.16%)

$74,213,000 (539.91%)

-$16,870,000 (-150.14%)

$33,646,000 (-4.50%)

Net Cash Flow from Operations

-$60,927,000 (-57.94%)

-$38,577,000 (-106.85%)

-$18,650,000 (32.38%)

-$27,582,000 (8.69%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$23,218,000 (-165.82%)

$35,274,000 (90.45%)

$18,521,000 (265.59%)

$5,066,000 (250.59%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$54,343,000 (47354.78%)

-$115,000 (94.55%)

Capital Expenditure

-$19,000 (94.75%)

-$362,000 (-19.87%)

-$302,000 (65.80%)

-$883,000 (39.93%)

Issuance (Repayment) of Debt Securities

-$924,000 (-102.10%)

$44,082,000 (200.71%)

-$43,771,000 (-980.70%)

$4,970,000 (-85.54%)

Issuance (Purchase) of Equity Shares

$39,792,000 (31.30%)

$30,307,000 (12.66%)

$26,901,000 (-6.19%)

$28,676,000 (6230.24%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,164,000 (-50.17%)

$14,376,000 (188.39%)

$4,985,000 (-17.64%)

$6,053,000 (-38.37%)

Depreciation Amortization & Accretion

$1,269,000 (51.79%)

$836,000 (16.43%)

$718,000 (52.12%)

$472,000 (106.11%)

VRCA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

63.80% (-25.29%)

85.40% (-7.17%)

92.00% (-8.00%)

100.00%

Profit Margin

-1012.10% (22.59%)

-1307.50% (-382.29%)

-271.10% (7.25%)

-292.30%

EBITDA Margin

-871.00% (28.24%)

-1213.80% (-407.65%)

-239.10% (5.34%)

-252.60%

Return on Average Equity (ROAE)

549.90% (474.08%)

-147.00% (-89.92%)

-77.40% (-3.34%)

-74.90% (22.30%)

Return on Average Assets (ROAA)

-149.10% (-72.17%)

-86.60% (-102.34%)

-42.80% (-14.75%)

-37.30% (26.72%)

Return on Sales (ROS)

-887.70% (27.84%)

-1230.20% (-397.86%)

-247.10% (3.66%)

-256.50%

Return on Invested Capital (ROIC)

-177.30% (32.48%)

-262.60% (-76.60%)

-148.70% (-214.38%)

-47.30% (32.14%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.47 (90.44%)

-4.95 (-29.51%)

-3.82 (45.80%)

-7.05 (-4.68%)

Price to Sales Ratio (P/S)

4.79 (-92.60%)

64.78 (522.72%)

10.4 (-49.61%)

20.64

Price to Book Ratio (P/B)

-3.24 (-120.78%)

15.58 (451.90%)

2.82 (-63.48%)

7.73 (-14.34%)

Debt to Equity Ratio (D/E)

-6.49 (-307.41%)

3.13 (2574.36%)

0.12 (-91.97%)

1.46 (16.75%)

Earnings Per Share (EPS)

-1.48 (0.00%)

-1.48 (-105.56%)

-0.72 (44.62%)

-1.3 (23.98%)

Sales Per Share (SPS)

0.15 (29.20%)

0.11 (-57.20%)

0.26 (-40.54%)

0.44 (0%)

Free Cash Flow Per Share (FCFPS)

-1.18 (-36.90%)

-0.86 (-54.77%)

-0.56 (47.29%)

-1.05 (16.89%)

Book Value Per Share (BVPS)

-0.19 (-143.58%)

0.44 (-62.80%)

1.17 (-2.82%)

1.21 (-8.64%)

Tangible Assets Book Value Per Share (TABVPS)

1.04 (-41.94%)

1.8 (37.51%)

1.31 (-55.82%)

2.96 (-0.13%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (75.00%)

-4 (0.00%)

-4 (55.56%)

-9 (-12.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.85 (80.21%)

-4.3 (-13.07%)

-3.8 (58.04%)

-9.06 (-12.57%)

Asset Turnover

0.15 (122.73%)

0.07 (-58.23%)

0.16 (23.44%)

0.13 (0%)

Current Ratio

1.76 (-61.26%)

4.55 (-59.73%)

11.31 (600.62%)

1.61 (-5.83%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$60,946,000 (-56.52%)

-$38,939,000 (-105.46%)

-$18,952,000 (33.42%)

-$28,465,000 (10.14%)

Enterprise Value (EV)

$56,074,556 (-79.03%)

$267,422,528 (225.61%)

$82,130,646 (-70.11%)

$274,755,525 (-13.46%)

Earnings Before Tax (EBT)

-$76,579,000 (-14.31%)

-$66,995,000 (-173.59%)

-$24,487,000 (30.20%)

-$35,080,000 (17.83%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$65,898,000 (-5.95%)

-$62,197,000 (-187.99%)

-$21,597,000 (28.75%)

-$30,313,000 (23.12%)

Invested Capital

$24,732,000 (-38.99%)

$40,536,000 (376.05%)

$8,515,000 (-86.21%)

$61,727,000 (0.86%)

Working Capital

$22,167,000 (-63.36%)

$60,506,000 (69.69%)

$35,656,000 (26.11%)

$28,273,000 (0.35%)

Tangible Asset Value

$54,134,000 (-33.66%)

$81,597,000 (82.46%)

$44,721,000 (-44.19%)

$80,125,000 (8.05%)

Market Capitalization

$31,920,556 (-89.63%)

$307,912,528 (172.47%)

$113,008,646 (-55.17%)

$252,074,525 (-15.33%)

Average Equity

-$13,925,750 (-130.55%)

$45,578,000 (44.06%)

$31,637,250 (-32.48%)

$46,855,750 (5.75%)

Average Assets

$51,344,500 (-33.66%)

$77,396,250 (35.24%)

$57,230,250 (-39.12%)

$94,003,250 (11.99%)

Invested Capital Average

$37,893,250 (57.85%)

$24,006,250 (59.94%)

$15,010,000 (-76.96%)

$65,136,750 (14.47%)

Shares

45,600,795 (8.41%)

42,064,553 (2.36%)

41,094,053 (49.33%)

27,519,053 (6.39%)